Results 31 to 40 of about 12,013,030 (353)

Research on the Promotion Strategy of Scientific and Technological Innovation Ability in Guangdong Vocational Colleges from the Perspective of “Double High” Construction [PDF]

SHS Web of Conferences, 2022
Improving the technological innovation ability of vocational colleges is a necessary condition for more precise docking of industrial needs and deeper development of school-enterprise integration, which is of great significance for deepening the ...
Dong Jian, Xie Jianru, Guo Yintong
doaj   +1 more source

Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case–control study

BMC Cardiovascular Disorders, 2022
Background Recent studies have raised concern about the association of fluoroquinolones with an increased risk of aortic aneurysm and aortic dissection. We aimed to evaluate such risk in a Korean population.
Nayeong Son, Eunmi Choi, Soo Youn Chung, Soon Young Han, Bonggi Kim   +4 more
doaj   +1 more source

Chinese expert consensus on the management of adverse reactions to HER2-targeted antibody-drug conjugates in digestive system cancers (2025 edition)

Zhongguo Linchuang Yixue
Digestive system cancers are very prevalent globally. Among these, human epidermal growth factor receptor 2 (HER2)-positive gastric cancer, colorectal cancer, and cholangiocarcinoma are tumors that require particular attention.
Committee on Antitumor Drug Safety Management, Chinese Society of Clinical Oncology (CSCO) Expert
doaj   +1 more source

Risk of genital and urinary tract infections associated with SGLT‐2 inhibitors as an add‐on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea

Pharmacology Research & Perspectives, 2022
Sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors are antidiabetic drugs with associated safety concerns regarding the risk of genital and urinary tract infections.
Hyeri Yang, Eunmi Choi, Eunjun Park, Eonji Na, Soo Youn Chung, Bonggi Kim, Soon Young Han   +6 more
doaj   +1 more source

Drug Management Reviews in District Drug Management Unit and General Hospital

Makara Journal of Health Research, 2010
Drug is one of the essential elements in healthcare that should be effectively and efficiently managed. Following the decentralization in 2001 in Indonesia, drug management has changed in district drug management units and also in District General ...
Max Joseph Herman, Rini Sasanti Handayani, Yuyun Yuniar   +2 more
doaj   +1 more source

A Blockchain and Machine Learning-Based Drug Supply Chain Management and Recommendation System for Smart Pharmaceutical Industry

Electronics, 2020
From the last decade, pharmaceutical companies are facing difficulties in tracking their products during the supply chain process, allowing the counterfeiters to add their fake medicines into the market.
Khizar Abbas, Muhammad Afaq, Talha Ahmed Khan, Wang-Cheol Song   +3 more
semanticscholar   +1 more source

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 1)

Zdorovʹe Rebenka, 2018
The review of the literature presents the classification of antioxidant drugs. Modern data are presented on the inhibitors of NOX activity such as natural, synthetic (non-selective and selective), renin-angiotensin-aldosterone system blo­cking drugs and ...
A.E. Abaturov, A.P. Volosovets, T.P. Borysova   +2 more
doaj   +1 more source

Narcotics information management system in South Korea: system development and innovation

BMC Health Services Research, 2023
Background As the misuse and abuse of medical narcotics are increasing in South Korea, an information system for the integrated information management of medical narcotic drugs across the nation is needed.
Sang-Yoon Kim, Nam-Wook Cho, Myung-Sik Yoo, Soon-Young Han, Jeong-Wyan Oh   +4 more
doaj   +1 more source

Contextualized Drug–Drug Interaction Management Improves Clinical Utility Compared With Basic Drug–Drug Interaction Management in Hospitalized Patients

Clinical Pharmacology & Therapeutics, 2022
Drug–drug interactions (DDIs) frequently trigger adverse drug events or reduced efficacy. Most DDI alerts, however, are overridden because of irrelevance for the specific patient. Basic DDI clinical decision support (CDS) systems offer limited possibilities for decreasing the number of irrelevant DDI alerts without missing relevant ones.
Arthur T.M. Wasylewicz, Britt W.M. van de Burgt, Thomas Manten, Marieke Kerskes, Wilma N. Compagner, Erik H.M. Korsten, Toine C.G. Egberts, Rene J.E. Grouls   +7 more
openaire   +5 more sources

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source